Moomoo AI 已提取核心信息
On February 21, 2024, Aclarion, Inc., a healthcare technology company, filed an amendment to its S-1 registration statement in connection with a proposed public offering. This amendment included audited financial statements for the fiscal years ended December 31, 2023, and December 31, 2022. The financial statements, which were furnished as Exhibit 99.1 to the Current Report on Form 8-K, revealed that Aclarion has been experiencing recurring losses from operations and has a shareholders' equity deficit, raising substantial doubt about its ability to continue as a going concern. The audited financial statements were prepared assuming the company will continue to operate, and no adjustments have been made that might result from the outcome of this uncertainty. The report was signed by John Lorbiecki, an authorized representative of Aclarion, Inc.
On February 21, 2024, Aclarion, Inc., a healthcare technology company, filed an amendment to its S-1 registration statement in connection with a proposed public offering. This amendment included audited financial statements for the fiscal years ended December 31, 2023, and December 31, 2022. The financial statements, which were furnished as Exhibit 99.1 to the Current Report on Form 8-K, revealed that Aclarion has been experiencing recurring losses from operations and has a shareholders' equity deficit, raising substantial doubt about its ability to continue as a going concern. The audited financial statements were prepared assuming the company will continue to operate, and no adjustments have been made that might result from the outcome of this uncertainty. The report was signed by John Lorbiecki, an authorized representative of Aclarion, Inc.
2024年2月21日，医疗保健技术公司Aclarion, Inc. 提交了与拟议的公开募股有关的S-1注册声明修正案。该修正案包括截至2023年12月31日和2022年12月31日的财政年度的经审计的财务报表。这些财务报表以表8-K最新报告附录99.1的形式提供，显示Aclarion一直遭受经常性运营亏损，股东权益赤字，这引发了人们对其继续经营能力的严重怀疑。经审计的财务报表是在假设公司将继续运营的情况下编制的，没有根据这种不确定性的结果进行任何可能导致的调整。该报告由Aclarion, Inc.的授权代表约翰·洛尔比茨基签署。
2024年2月21日，医疗保健技术公司Aclarion, Inc. 提交了与拟议的公开募股有关的S-1注册声明修正案。该修正案包括截至2023年12月31日和2022年12月31日的财政年度的经审计的财务报表。这些财务报表以表8-K最新报告附录99.1的形式提供，显示Aclarion一直遭受经常性运营亏损，股东权益赤字，这引发了人们对其继续经营能力的严重怀疑。经审计的财务报表是在假设公司将继续运营的情况下编制的，没有根据这种不确定性的结果进行任何可能导致的调整。该报告由Aclarion, Inc.的授权代表约翰·洛尔比茨基签署。
有用
没用
